A Novel Strategy for Screening Active Components in Cistanche tubulosa Based on Spectrum-Effect Relationship Analysis and Network Pharmacology

Table 1

Contents of 11 batches of C. tubulosa.

	HM					WE					HR
	Geniposidic acid (mg/g)	Echinacoside (mg/g)	Verbascoside (mg/g)	Tubuloside A (mg/g)	Isoacteoside (mg/g)	Geniposidic acid (mg/g)	Echinacoside (mg/g)	Verbascoside (mg/g)	Tubuloside A (mg/g)	Isoacteoside (mg/g)	Geniposidic acid (mg/g)	Echinacoside (mg/g)	Verbascoside (mg/g)	Tubuloside A (mg/g)	Isoacteoside (mg/g)
S1	1.02	30.54	5.30	4.64	1.10	1.98	57.58	5.13	5.58	8.09	0.34	20.09	1.92	2.81	2.92
S2	1.99	5.99	1.34	0.11	0.24	2.51	8.59	1.07	—	1.39	0.55	2.05	0.23	—	0.37
S3	1.58	8.80	2.19	0.25	0.41	2.01	15.85	2.02	0.60	1.85	0.34	5.16	0.58	0.17	0.60
S4	7.89	18.43	2.50	1.17	0.90	8.96	35.41	1.61	1.21	3.72	0.77	11.15	0.81	0.86	0.95
S5	0.97	32.31	6.46	2.67	0.95	1.38	13.01	1.58	0.43	1.52	0.30	9.74	1.22	0.87	1.00
S6	0.39	16.82	4.62	0.26	1.15	0.45	14.00	2.31	0.29	2.50	0.06	11.62	1.50	0.81	1.63
S7	0.69	34.69	6.45	3.75	1.24	0.70	13.83	1.33	0.63	1.53	0.19	9.99	1.08	1.03	0.92
S8	0.60	12.00	3.53	1.18	0.37	0.50	6.53	0.57	—	1.15	0.12	1.70	0.17	—	0.32
S9	0.59	75.95	7.14	3.48	1.52	1.03	127.43	5.89	4.46	11.80	0.34	24.70	1.30	0.93	2.08
S10	0.58	9.43	3.21	0.42	0.66	0.53	16.35	3.12	0.39	3.19	0.22	2.72	0.43	0.23	0.44
S11	0.42	2.18	0.98	0.11	0.13	0.79	4.55	0.92	—	0.62	0.25	2.28	0.38	—	0.41